Impact of an HPV Primary Prevention Intervention on HPV Vaccination Rates Among Adolescents in the AuRA Region.

Recruiting N/A Interventional Study
Middle School and High School Students
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
11 – 17
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
1,422 (estimated)
Sponsor
Centre Leon Berard · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Human papillomaviruses (HPV) are very common contagious viruses: approximately 70% of men and women will be infected during their lifetime. Vaccination, recommended since 2007 for girls and since 2021 for all young people aged 11 to 14 (with catch-up vaccination possible up to age 26), remains insufficiently followed. Today, only 40.7% of adolescents are vaccinated in France, and the Auvergne Rhôn…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria for children : * Girl or boy, student at a public school participating in the study * Aged 11 to 17 * Having received an information sheet about the study and having signed a declaration of non-objection * Whose parents have also received an information sheet and have not express…
Contacts

Carmen DUPUIS, PhD

0469856218

carmen.dupuis@lyon.unicancer.fr

CONTACT

Olivia PEROL, PhD

0478782897

olivia.perol@lyon.unicancer.fr

CONTACT